School of Chemical Engineering, University of Adelaide, Adelaide, 5005, Australia.
Adv Healthc Mater. 2024 Aug;13(21):e2302436. doi: 10.1002/adhm.202302436. Epub 2024 Jan 26.
Microfluidic chips are valuable tools for studying intricate cellular and cell-microenvironment interactions. Traditional in vitro cancer models lack accuracy in mimicking the complexities of in vivo tumor microenvironment. However, cancer-metastasis-on-a-chip (CMoC) models combine the advantages of 3D cultures and microfluidic technology, serving as powerful platforms for exploring cancer mechanisms and facilitating drug screening. These chips are able to compartmentalize the metastatic cascade, deepening the understanding of its underlying mechanisms. This article provides an overview of current CMoC models, focusing on distinctive models that simulate invasion, intravasation, circulation, extravasation, and colonization, and their applications in drug screening. Furthermore, challenges faced by CMoC and microfluidic technologies are discussed, while exploring promising future directions in cancer research. The ongoing development and integration of these models into cancer studies are expected to drive transformative advancements in the field.
微流控芯片是研究复杂细胞和细胞微环境相互作用的有价值的工具。传统的体外癌症模型在模拟体内肿瘤微环境的复杂性方面缺乏准确性。然而,癌症转移芯片(CMoC)模型结合了 3D 培养和微流控技术的优势,是探索癌症机制和促进药物筛选的强大平台。这些芯片能够分隔转移级联,加深对其潜在机制的理解。本文概述了当前的 CMoC 模型,重点介绍了模拟侵袭、浸润、循环、渗出和定植的独特模型,以及它们在药物筛选中的应用。此外,还讨论了 CMoC 和微流控技术面临的挑战,同时探索了癌症研究中具有前景的未来方向。这些模型的不断发展和整合有望推动该领域的变革性进展。